Inventor
Stacy W. Remiszewski
Inventor
Washington Township, NJ, US
Overview
Patents· 38 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes22%
C07CAcyclic or carbocyclic compounds4%
C04BLime, magnesia3%
C07KPeptides2%
G07BTicket-issuing apparatus1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,723,708Anti-HCMV compositions and methods202010,556,894Anti-HCMV compositions and methods202010,053,431Tetrahydro-benzodiazepinones20189,611,224'Antiproliferative benzo [B] azepin-2-ones'20179,422,331'2-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancer'20169,422,332'Azaheterocycles as BIR2 and/or BIR3 inhibitors'20169,403,768'Indolines'20169,394,263'Substituted hetero-azepinones'20167,067,551'Deacetylase inhibitors'20066,833,384'Deacetylase inhibitors'20046,699,872'N-substituted urea inhibitors of farnesyl-protein transferase'20046,576,639'Compounds for the inhibition of farnesyl protein transferase'20036,552,065'Deacetylase inhibitors'20036,492,381'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'20026,410,541'Compounds useful for inhibition of farnesyl protein transferase'20026,387,905'Compounds useful for inhibition of farnesyl protein transferase'20026,365,588'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'20026,358,968'N-substituted urea inhibitors of farnesyl-protein transferase'20026,300,338'Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases'20016,277,854'Tricyclic antitumor farnesyl protein transferase inhibitors'20016,242,458'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'20016,228,856'Compounds useful for inhibition of farnesyl protein transferase'20016,214,828'Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease'20016,211,193'Compounds useful for inhibition of farnesyl protein transferase'20016,143,758'Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases'20006,075,025'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'20006,030,982'Compounds useful for inhibition of farnesyl protein transferase'20005,994,364'Tricyclic antitumor farnesyl protein transferase inhibitors'19995,977,128'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'19995,939,416'Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors'19995,874,442'Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease'19995,861,395'Compounds useful for inhibition of farnesyl proteins transferase'19995,807,853'Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases'19985,728,703'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'19985,721,236'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'19985,719,148'Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases'19985,714,609'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'19985,696,121'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2004Patents assigned to SCHERING CORP (26)· patent assignee history
1997–2017Based in Washington Township, NJ, US· patent location history
2002Based in Township of Washington, NJ, US· patent location history
2003–2006Patents assigned to NOVARTIS AG (3)· patent assignee history
2016–2018Patents assigned to HOFFMANN LA ROCHE (6)· patent assignee history
2016–2018Based in Washington, NJ, US· patent location history
2020Patents assigned to EVRYS BIO LLC (2)· patent assignee history
2020Patents assigned to FORGE LIFE SCIENCE LLC (2)· patent assignee history
2020Based in Doylestown, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING CORP | 26 | 1997–2004 |
| HOFFMANN LA ROCHE | 6 | 2016–2018 |
| NOVARTIS AG | 3 | 2003–2006 |
| EVRYS BIO LLC | 2 | 2020 |
| FORGE LIFE SCIENCE LLC | 2 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Washington Township, New Jersey, US | 33 | 1997–2017 |
| Doylestown, Pennsylvania, US | 2 | 2020 |
| Washington, New Jersey, US | 2 | 2016–2018 |
| Township of Washington, New Jersey, US | 1 | 2002 |